{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:40:30Z","timestamp":1790797230676,"version":"4.1.0"},"reference-count":65,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,5,23]],"date-time":"2018-05-23T00:00:00Z","timestamp":1527033600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["H2020 - ERC-2014-PoC 641232 - Fingers4Cure"],"award-info":[{"award-number":["H2020 - ERC-2014-PoC 641232 - Fingers4Cure"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Physiol."],"DOI":"10.3389\/fphys.2018.00559","type":"journal-article","created":{"date-parts":[[2018,5,23]],"date-time":"2018-05-23T09:33:17Z","timestamp":1527067997000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":45,"title":["Neuro-Cardio Mechanisms in Huntington\u2019s Disease and Other Neurodegenerative Disorders"],"prefix":"10.3389","volume":"9","author":[{"given":"Bethan J.","family":"Critchley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Isalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Mielcarek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,5,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.coph.2007.12.002","article-title":"Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders.","volume":"8","author":"Abel","year":"2008","journal-title":"Curr. Opin. Pharmacol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1750-3639.2005.tb00097.x","article-title":"Profound cardiac sympathetic denervation occurs in Parkinson disease.","volume":"15","author":"Amino","year":"2005","journal-title":"Brain Pathol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1136\/jnnp.72.6.726","article-title":"Autonomic nervous system function in Huntington\u2019s disease.","volume":"72","author":"Andrich","year":"2002","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1212\/WNL.0000000000000434","article-title":"Brugada syndrome in spinal and bulbar muscular atrophy.","volume":"82","author":"Araki","year":"2014","journal-title":"Neurology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1056\/NEJMp058027","article-title":"Genetic factors in Alzheimer\u2019s disease.","volume":"352","author":"Bird","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.13289","article-title":"Neurocardiovascular deficits in the Q175 mouse model of Huntington\u2019s disease.","volume":"5","author":"Cutler","year":"2017","journal-title":"Physiol. Rep."},{"key":"B7","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson\u2019s disease: mechanisms and models.","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"B8","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0076-6879(99)09045-X","article-title":"Detection of polyglutamine aggregation in mouse models.","volume":"309","author":"Davies","year":"1999","journal-title":"Methods Enzymol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1097\/HCO.0b013e328352220e","article-title":"Cardiac connexins, mutations and arrhythmias.","volume":"27","author":"Delmar","year":"2012","journal-title":"Curr. Opin. Cardiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.tcm.2012.06.015","article-title":"L-type Ca2+ channel function during Timothy syndrome.","volume":"22","author":"Dixon","year":"2012","journal-title":"Trends Cardiovasc. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1161\/CIRCRESAHA.113.300376","article-title":"Cardiac metabolism in heart failure: implications beyond Atp production.","volume":"113","author":"Doenst","year":"2013","journal-title":"Circ. Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1101\/gad.13.21.2801","article-title":"Mice lacking both presenilin genes exhibit early embryonic patterning defects.","volume":"13","author":"Donoviel","year":"1999","journal-title":"Genes Dev."},{"key":"B13","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1161\/STROKEAHA.108.534388","article-title":"Dysfunctional cell-cell signaling in the neurovascular unit as a paradigm for central nervous system disease.","volume":"40","author":"Guo","year":"2009","journal-title":"Stroke"},{"key":"B14","first-page":"125","article-title":"Modeling and imaging cardiac sympathetic neurodegeneration in Parkinson\u2019s disease.","volume":"4","author":"Joers","year":"2014","journal-title":"Am. J. Nucleic Med. Mol.Imaging"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/srep25979","article-title":"Impaired nitric oxide mediated vasodilation in the peripheral circulation in the R6\/2 mouse model of Huntington\u2019s disease.","volume":"6","author":"Kane","year":"2016","journal-title":"Sci. Rep."},{"key":"B16","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1212\/WNL.0000000000002858","article-title":"Huntington disease reduced penetrance alleles occur at high frequency in the general population.","volume":"87","author":"Kay","year":"2016","journal-title":"Neurology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"5845","DOI":"10.1113\/jphysiol.2012.238113","article-title":"Neurocardiac dysregulation and neurogenic arrhythmias in a transgenic mouse model of Huntington\u2019s disease.","volume":"590","author":"Kiriazis","year":"2012","journal-title":"J. Physiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.jns.2016.10.033","article-title":"Functional impairment of precerebral arteries in Huntington disease.","volume":"372","author":"Kobal","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1111\/j.1600-0404.2009.01251.x","article-title":"Autonomic dysfunction in presymptomatic and early symptomatic Huntington\u2019s disease.","volume":"121","author":"Kobal","year":"2010","journal-title":"Acta Neurol. Scand."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0116396","article-title":"The pathogenesis of cardiomyopathy in Friedreich ataxia.","volume":"10","author":"Koeppen","year":"2015","journal-title":"PLoS One"},{"key":"B21","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.expneurol.2010.12.011","article-title":"Dysfunctions in circadian behavior and physiology in mouse models of Huntington\u2019s disease.","volume":"228","author":"Kudo","year":"2011","journal-title":"Exp. Neurol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1042\/BJ20130079","article-title":"Biochemistry of cardiomyopathy in the mitochondrial disease Friedreich\u2019s ataxia.","volume":"453","author":"Lane","year":"2013","journal-title":"Biochem. J."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1086\/509900","article-title":"Mutations of presenilin genes in dilated cardiomyopathy and heart failure.","volume":"79","author":"Li","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"B24","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.tig.2004.01.008","article-title":"Huntingtin-protein interactions and the pathogenesis of Huntington\u2019s disease.","volume":"20","author":"Li","year":"2004","journal-title":"Trends Genet."},{"key":"B25","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.expneurol.2013.08.019","article-title":"Neurovascular abnormalities in humans and mice with Huntington\u2019s disease.","volume":"250","author":"Lin","year":"2013","journal-title":"Exp. Neurol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"3451","DOI":"10.1161\/CIRCULATIONAHA.105.572552","article-title":"Mitochondrial dysfunction and apoptosis underlie the pathogenic process in alpha-B-crystallin desmin-related cardiomyopathy.","volume":"112","author":"Maloyan","year":"2005","journal-title":"Circulation"},{"key":"B27","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s00415-011-6279-3","article-title":"Microcirculation response to local cooling in patients with Huntington\u2019s disease.","volume":"259","author":"Melik","year":"2012","journal-title":"J. Neurol."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004024","article-title":"Huntington\u2019s disease induced cardiac amyloidosis is reversed by modulating protein folding and oxidative stress pathways in the Drosophila heart.","volume":"9","author":"Melkani","year":"2013","journal-title":"PLoS Genet."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1080\/21675511.2015.1058464","article-title":"Huntington\u2019s disease is a multi-system disorder.","volume":"3","author":"Mielcarek","year":"2015","journal-title":"Rare Dis."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0108961","article-title":"The Huntington\u2019s disease-related cardiomyopathy prevents a hypertrophic response in the R6\/2 mouse model.","volume":"9","author":"Mielcarek","year":"","journal-title":"PLoS One"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004550","article-title":"Dysfunction of the CNS-heart axis in mouse models of Huntington\u2019s disease.","volume":"10","author":"Mielcarek","year":"","journal-title":"PLoS Genet."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1186\/s40169-015-0076-z","article-title":"A shared mechanism of muscle wasting in cancer and Huntington\u2019s disease.","volume":"4","author":"Mielcarek","year":"2015","journal-title":"Clin. Transl. Med."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1001717","article-title":"HDAC4 reduction: a novel therapeutic strategy to target cytoplasmic huntingtin and ameliorate neurodegeneration.","volume":"11","author":"Mielcarek","year":"2013","journal-title":"PLoS Biol."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2014-309032.281","article-title":"Myostatin inhibition as a novel approach to targeting muscle pathology in HD.","volume":"85","author":"Mielcarek","year":"","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2017.00127","article-title":"Transcriptional signature of an altered purine metabolism in the skeletal muscle of a Huntington\u2019s disease mouse model.","volume":"8","author":"Mielcarek","year":"2017","journal-title":"Front. Physiol."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1005021","article-title":"Hdac4-myogenin axis as an important marker of Hd-related skeletal muscle atrophy.","volume":"11","author":"Mielcarek","year":"","journal-title":"PLoS Genet."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2015.00042","article-title":"HDAC4 as a potential therapeutic target in neurodegenerative diseases: a summary of recent achievements.","volume":"9","author":"Mielcarek","year":"","journal-title":"Front. Cell Neurosci."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008025","article-title":"Formation of polyglutamine inclusions in a wide range of non-CNS tissues in the HdhQ150 knock-in mouse model of Huntington\u2019s disease.","volume":"4","author":"Moffitt","year":"2009","journal-title":"PLoS One"},{"key":"B39","doi-asserted-by":"publisher","first-page":"307","DOI":"10.2217\/nmt-2017-0019","article-title":"A survey-based study identifies common but unrecognized symptoms in a large series of juvenile Huntington\u2019s disease.","volume":"7","author":"Moser","year":"2017","journal-title":"Neurodegener. Dis. Manag."},{"key":"B40","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1002\/dvdy.20098","article-title":"Presenilin 1 is essential for cardiac morphogenesis.","volume":"230","author":"Nakajima","year":"2004","journal-title":"Dev. Dyn."},{"key":"B41","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.parkreldis.2012.07.005","article-title":"Alpha-synuclein aggregates in epicardial fat tissue in living subjects without parkinsonism.","volume":"19","author":"Navarro-Otano","year":"2013","journal-title":"Parkinsonism Relat. Disord."},{"key":"B42","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1136\/bcr-2017-221354","article-title":"Anaesthesia and orphan disease: airway and anaesthetic management in Huntington\u2019s disease.","volume":"2017","author":"Nguyen","year":"2017","journal-title":"BMJ Case Rep."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1161\/CIRCULATIONAHA.107.750232","article-title":"Cardiomyocyte expression of a polyglutamine preamyloid oligomer causes heart failure.","volume":"117","author":"Pattison","year":"2008","journal-title":"Circulation"},{"key":"B44","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1007\/s00246-011-9943-6","article-title":"Cardiomyopathy of Friedreich\u2019s ataxia: use of mouse models to understand human disease and guide therapeutic development.","volume":"32","author":"Payne","year":"2011","journal-title":"Pediatr. Cardiol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3233\/JHD-2012-120006","article-title":"Hypothalamic and limbic system changes in Huntington\u2019s disease.","volume":"1","author":"Petersen","year":"2012","journal-title":"J. Huntingtons Dis."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0180571","article-title":"Early transcriptional alteration of histone deacetylases in a murine model of doxorubicin-induced cardiomyopathy.","volume":"12","author":"Piotrowska","year":"2017","journal-title":"PLoS One"},{"key":"B47","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/bpa.12115","article-title":"Huntington\u2019s disease (Hd): degeneration of select nuclei, widespread occurrence of neuronal nuclear and axonal inclusions in the brainstem.","volume":"24","author":"Rub","year":"2014","journal-title":"Brain Pathol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"13592","DOI":"10.1073\/pnas.0503324102","article-title":"Reversal of amyloid-induced heart disease in desmin-related cardiomyopathy.","volume":"102","author":"Sanbe","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0147269","article-title":"Cardiac dysfunction in the bachd mouse model of Huntington\u2019s Disease.","volume":"11","author":"Schroeder","year":"2016","journal-title":"PLoS One"},{"key":"B50","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.cell.2004.09.011","article-title":"Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism.","volume":"119","author":"Splawski","year":"2004","journal-title":"Cell"},{"key":"B51","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.84.14_supplement.P5.294","article-title":"Huntington\u2019s disease and the heart: electrocardiogram abnormalities suggest cardiac involvement.","volume":"84","author":"Stephen","year":"2015","journal-title":"Neurology"},{"key":"B52","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/ng1193-259","article-title":"Widespread expression of the human and rat Huntington\u2019s disease gene in brain and nonneural tissues.","volume":"5","author":"Strong","year":"1993","journal-title":"Nat. Genet."},{"key":"B53","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1007\/s00415-013-7005-0","article-title":"Cardiac sympathetic function in the patients with amyotrophic lateral sclerosis: analysis using cardiac [123I] Mibg scintigraphy.","volume":"260","author":"Tanaka","year":"2013","journal-title":"J. Neurol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1080\/15257770.2016.1154969","article-title":"Changes in cardiac nucleotide metabolism in Huntington\u2019s disease.","volume":"35","author":"Toczek","year":"","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"B55","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1016\/j.bbadis.2016.08.019","article-title":"An impaired metabolism of nucleotides underpins a novel mechanism of cardiac remodeling leading to Huntington\u2019s disease related cardiomyopathy.","volume":"1862","author":"Toczek","year":"","journal-title":"Biochim. Biophys. Acta"},{"key":"B56","author":"Tunah","year":"2012","journal-title":"Modeling Huntington\u2019s Disease: in vivo, in vitro, in silico - \u201cHuntington\u2019s Disease - Core Concepts and Current Advances\u201d"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0006033","article-title":"Cardiomyocyte contractile dysfunction in the APPswe\/PS1dE9 mouse model of Alzheimer\u2019s disease.","volume":"4","author":"Turdi","year":"2009","journal-title":"PLoS One"},{"key":"B58","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","article-title":"Huntington\u2019s disease.","volume":"369","author":"Walker","year":"2007","journal-title":"Lancet"},{"key":"B59","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3233\/JHD-2012-120004","article-title":"Direct evidence of progressive cardiac dysfunction in a transgenic mouse model of Huntington\u2019s disease.","volume":"1","author":"Wood","year":"2012","journal-title":"J. Huntingtons Dis."},{"key":"B60","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s12012-015-9318-y","article-title":"Cardiac Fas-Dependent and mitochondria-dependent apoptotic pathways in a transgenic mouse model of Huntington\u2019s Disease.","volume":"16","author":"Wu","year":"2015","journal-title":"Cardiovasc. Toxicol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.bbadis.2014.11.003","article-title":"Sarcomeric protein isoform transitions in cardiac muscle: a journey to heart failure.","volume":"1852","author":"Yin","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"B62","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.parkreldis.2014.12.013","article-title":"Update on Huntington\u2019s disease: advances in care and emerging therapeutic options.","volume":"21","author":"Zielonka","year":"2015","journal-title":"Parkinsonism Relat. Disord."},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2014.00380","article-title":"Skeletal muscle pathology in Huntington\u2019s disease.","volume":"5","author":"Zielonka","year":"","journal-title":"Front. Physiol."},{"key":"B64","first-page":"2547","article-title":"Cardiac dysfunction in Huntington\u2019s Disease.","volume":"20","author":"Zielonka","year":"","journal-title":"Exp. Clin. Cardiol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nrn3114","article-title":"Neurovascular pathways to neurodegeneration in Alzheimer\u2019s disease and other disorders.","volume":"12","author":"Zlokovic","year":"2011","journal-title":"Nat. Rev. Neurosci."}],"container-title":["Frontiers in Physiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphys.2018.00559\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T23:00:50Z","timestamp":1720306850000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphys.2018.00559\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,23]]},"references-count":65,"alternative-id":["10.3389\/fphys.2018.00559"],"URL":"https:\/\/doi.org\/10.3389\/fphys.2018.00559","relation":{},"ISSN":["1664-042X"],"issn-type":[{"value":"1664-042X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,23]]},"article-number":"559"}}